NPs More in Demand Than Docs

Combined, PAs and NPs represent Merritt Hawkins’ third most sought HCPs in the 2017 Review, which is up from fifth in 2016. This year’s third place is the highest position PAs and NPs have held on the physician recruiter and staffing firm’s list showing an increase in demand…Continue reading

FacebookTwitter

PAs Enjoy a Victory

On May 25, Walgreens changed their electronic voice service to include “physician assistant” as an example of a provider. It seems like a small change but it is a great victory for PAs who can prescribe and treat along with NPs and physicians. There are more than 115,500 certified PAs…Continue reading

FacebookTwitter

PAs Fight for Autonomy

At last week’s annual conference of the American Academy of PAs (AAPA), members unanimously approved Optimal Team Practice (OTP), a new policy which among other things supports the elimination of provisions in laws and regulations that require a PA to have or report a supervisory, collaborating or other specific relationship…Continue reading

FacebookTwitter

New Neurology Drug Generates Excitement

For the first time in 22 years, the FDA approved a new drug to treat ALS. Based only on clinical trial data generated from Japan, the FDA approved Radicava (edaravone) less than a year after the application for the medication was submitted. Research in Japan shows the drug slows muscle…Continue reading

FacebookTwitter

The Biggest Issue Facing Clinical Trials

Last week was Clinical Trials Awareness Week. The Coalition for Clinical Trials Awareness (CCTA) is a nonprofit group of HCPs, patient advocates, medical researchers and industry and government stakeholders working for a common goal: to increase public awareness about the importance of clinical trials participation.  The Tufts Center…Continue reading

FacebookTwitter
1 2 3 4 8